Hy2Care® BV

Hy2Care® BV is a Dutch biomedical company focused on injectable hydrogel technology for cartilage repair and osteoarthritis treatment. Founded in 2014 as a spin-off from the University of Twente, the company is dedicated to enabling painless mobility for all. With fewer than 25 employees, Hy2Care is headquartered in Enschede, Netherlands, and operates laboratory facilities at the University of Twente and the Brightlands Chemelot Campus in Geleen.

The company's primary product, CartRevive®, is a bioresorbable hydrogel implant designed for treating cartilage defects through arthroscopic procedures. This innovative hydrogel solidifies within the body after injection and integrates with surrounding cartilage and bone, enhancing the repair process. Hy2Care is also exploring applications in veterinary medicine and has identified significant market opportunities in wound care and cell therapy. The company collaborates with various partners to leverage scientific expertise and drive development in its field.